INVA

Q: What is the price of Innoviva (INVA) today?

The price of Innoviva (INVA) today is $ 20.63, with return of 11.03% compared to the last year. The price of Innoviva (INVA) started the year trading around $ 17.35 and today it is at $ 20.63. Follow the real-time price chart, the historical price of Innoviva (INVA) and international markets.

Q: When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not distribute dividends in the last year.

Q: Is Innoviva (INVA) worth it?

Currently, Innoviva (INVA) is priced at $ 20.63, with a P/E of 11.24%, representing a deviation of 1,475% from its historical average P/E. In the last year, the stock showed a variation of 11.03 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 11.03%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Innoviva (INVA) stock?

Investing in stocks of Innoviva (INVA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Innoviva (INVA) yield today?

The yield of Innoviva (INVA) was -7.07% in the last month, 11.03% in the last year and 74.76% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Innoviva (INVA) today, the total investment would be $ 2,063.00, based on the current price of $ 20.63.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,290.55In 5 years: $ 3,605.30In 10 years: $ 4,222.14It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Innoviva Inc.

Price

$ 20.63

return (12m)

11.03%

p/e

11.24

p/bv

1.42

DIVIDEND YIELD

0.00%

price INVA

INVA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of INVA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.07%

3 months

6.50%

1 year

11.03%

2 years

34.14%

5 years

74.76%

10 years

104.66%

Fundamentals INVA

review the fundamentals of Innoviva shares

P/E

11.24

Sector: -3.74 Industry: -3.74

P/SALES RATIO (PSR)

3.68

Sector: -3.71 Industry: -3.71

P/BV

1.42

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

8.91%

Sector: -63.91% Industry: -63.91%

ROE

12.61%

Sector: -67.36% Industry: -67.36%

ROIC

14.49%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

32.78%

Sector: -41.63% Industry: -41.63%

GROSS MARGIN

84.85%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

43.22%

Sector: -41.51% Industry: -41.51%

P/EBITDA

7.13

Sector: -3.78 Industry: -3.78

P/EBIT

8.19

Sector: -3.91 Industry: -3.91

P/ASSET

1.00

Sector: 1.49 Industry: 1.49

BVPS

14.64

Sector: 1.73 Industry: 1.73

EPS

1.85

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.71

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

2.90%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-10.71%

Sector: - Industry: -

FAIR VALUE OF Innoviva ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 20.63

Fair Value

$ 0.00

Upside Return potential.

19.66%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals INVA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.36	0.00	0.00%	2.52%	$ 486.25 B	27.26%
PFE	15.06	1.59	10.56%	6.61%	$ 147.98 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	13.80	7.96	57.70%	3.53%	$ 212.69 B	32.78%
MRK	13.09	0.00	0.00%	3.25%	$ 249.10 B	29.63%
AZN	29.76	6.09	20.45%	1.74%	$ 279.74 B	16.17%
BMY	17.58	5.71	32.47%	4.76%	$ 106.18 B	12.57%
GILD	18.58	7.02	37.80%	2.59%	$ 150.68 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.56 B	28.21%
HALO	12.44	14.70	118.17%	0.00%	$ 7.41 B	47.91%
REGN	16.32	2.41	14.79%	0.49%	$ 74.71 B	32.13%
AMGN	25.34	18.45	72.82%	2.85%	$ 177.48 B	19.47%
VRTX	31.73	6.73	21.22%	0.00%	$ 116.60 B	31.35%
MCK	24.84	-173.31	-697.75%	0.37%	$ 100.18 B	1.04%
CAH	29.67	-17.33	-58.40%	1.02%	$ 47.32 B	0.68%
ADMA	22.65	11.00	48.57%	0.00%	$ 4.74 B	42.87%
BIIB	16.57	1.46	8.83%	0.00%	$ 26.65 B	15.98%
HRMY	12.44	2.77	22.24%	0.00%	$ 2.31 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

INVA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	09/10/2015	09/30/2015	0,25000000
Dividend	06/12/2015	06/30/2015	0,25000000
Dividend	03/12/2015	03/31/2015	0,25000000
Dividend	11/25/2014	12/23/2014	0,25000000
Dividend	08/28/2014	09/18/2014	0,25000000

ABOUT THE COMPANY Innoviva

Innoviva Inc.

Average user rating I10

4.0 (0 people)

United States

29 years

Founded: 1996

2004

Time since IPO - 21 years

5

Employees

The Company Innoviva Inc. (United States), is listed on Nasdaq with a market value of $ 1.43 Billion, having an equity of $ 1.01 Billion.

With a total of 5 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 388.52 Millions, which generated a profit in the amount of $ 127.35 Millions.

As for its main indicators, the Company has a P/E ratio of 11.24, a P/BV ratio of 1.42 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker INVA.

Market cap

$ 1.43 Billion

Net worth

$ 1.01 Billion

US$ 1,009,950,000.00

Assets

$ 1.43 Billion

US$ 1,429,110,000.00

Total Shares Outstanding

69.00 Millions

69,000,000

Average Daily Trading Volume

$ 818.78 Thousand

US$ 818,784.38

Sector

Health Care

Industry

Biotechnology

INVA

INVA revenue and profits

Financial Results INVA

DRAG THE FRAME TO SEE MORE DATA

INVA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 813.80 41,98% (12M)

P/E

24.84

0.37%

ROE

-697.75%

P/BV

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12M)

P/E

29.67

1.02%

ROE

-58.40%

P/BV

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12M)

P/E

19.36

2.52%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12M)

P/E

13.09

3.25%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.85 9,78% (12M)

P/E

15.06

6.61%

ROE

10.56%

P/BV

1.59

ABBV - AbbVie

$ 223.32 34,34% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12M)

P/E

29.76

1.74%

ROE

20.45%

P/BV

6.09

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 813.80 41,98% (12 M)

P/L

24.84

0.37%

ROE

-697.75%

P/VP

-173.31

CAH - Cardinal Health

$ 198.18 70,66% (12 M)

P/L

29.67

1.02%

ROE

-58.40%

P/VP

-17.33

JNJ - Johnson & Johnson

$ 211.58 48,72% (12 M)

P/L

19.36

2.52%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.30 2,85% (12 M)

P/L

13.09

3.25%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.85 9,78% (12 M)

P/L

15.06

6.61%

ROE

10.56%

P/VP

1.59

ABBV - AbbVie

$ 223.32 34,34% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 89.83 37,80% (12 M)

P/L

29.76

1.74%

ROE

20.45%

P/VP

6.09

Frequently Asked Questions

What is the price of Innoviva (INVA) today?

The price of Innoviva (INVA) today is $ 20.63, with return of 11.03% compared to the last year. The price of Innoviva (INVA) started the year trading around $ 17.35 and today it is at $ 20.63. Follow the real-time price chart, the historical price of Innoviva (INVA) and international markets.

When does Innoviva (INVA) pay dividends?

Innoviva (INVA) did not distribute dividends in the last year.

Is Innoviva (INVA) worth it?

Currently, Innoviva (INVA) is priced at $ 20.63, with a P/E of 11.24%, representing a deviation of 1,475% from its historical average P/E. In the last year, the stock showed a variation of 11.03 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 11.03%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Innoviva (INVA) stock?

Investing in stocks of Innoviva (INVA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Innoviva (INVA) yield today?

The yield of Innoviva (INVA) was -7.07% in the last month, 11.03% in the last year and 74.76% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Innoviva (INVA) today, the total investment would be $ 2,063.00, based on the current price of $ 20.63.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 2,290.55
In 5 years: $ 3,605.30
In 10 years: $ 4,222.14

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

INVA

Innoviva Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of INVA

review the fundamentals of Innoviva shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Innoviva

Innoviva Inc.

United States

29 years

2004

5

PROFIT X PRICE INVA

Financial Results INVA

INVA cash flow

asset growth - INVA

INVA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions